Cargando…

Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models

Alzheimer’s disease (AD) is a major neurodegenerative disease, but so far, it can only be treated symptomatically rather than changing the process of the disease. Recently, triazoles and their derivatives have been shown to have potential for the treatment of AD. In this study, the neuroprotective e...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Fengmao, Xuan, Xinran, Liu, Zheng, Bian, Ming, Shen, Qingkun, Quan, Zheshan, Zhang, Guowei, Wei, Chengxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370156/
https://www.ncbi.nlm.nih.gov/pubmed/35956985
http://dx.doi.org/10.3390/molecules27155035
_version_ 1784766703482175488
author An, Fengmao
Xuan, Xinran
Liu, Zheng
Bian, Ming
Shen, Qingkun
Quan, Zheshan
Zhang, Guowei
Wei, Chengxi
author_facet An, Fengmao
Xuan, Xinran
Liu, Zheng
Bian, Ming
Shen, Qingkun
Quan, Zheshan
Zhang, Guowei
Wei, Chengxi
author_sort An, Fengmao
collection PubMed
description Alzheimer’s disease (AD) is a major neurodegenerative disease, but so far, it can only be treated symptomatically rather than changing the process of the disease. Recently, triazoles and their derivatives have been shown to have potential for the treatment of AD. In this study, the neuroprotective effects of 4-(4-(heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one (W112) against β-amyloid (Aβ)-induced AD pathology and its possible mechanism were explored both in vitro and in vivo. The results showed that W112 exhibits a neuroprotective role against Aβ-induced cytotoxicity in PC12 cells and improves the learning and memory abilities of Aβ-induced AD-like rats. In addition, the assays of the protein expression revealed that W112 reversed tau hyperphosphorylation and reduced the production of proinflammatory cytokines, tumor necrosis factor-α and interleukin-6, both in vitro and in vivo studies. Further study indicated that the regulation of mitogen-activated protein kinase/nuclear factor-κB pathways played a key role in mediating the neuroprotective effects of W112 against AD-like pathology. W112 may become a potential drug for AD intervention.
format Online
Article
Text
id pubmed-9370156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93701562022-08-12 Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models An, Fengmao Xuan, Xinran Liu, Zheng Bian, Ming Shen, Qingkun Quan, Zheshan Zhang, Guowei Wei, Chengxi Molecules Article Alzheimer’s disease (AD) is a major neurodegenerative disease, but so far, it can only be treated symptomatically rather than changing the process of the disease. Recently, triazoles and their derivatives have been shown to have potential for the treatment of AD. In this study, the neuroprotective effects of 4-(4-(heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one (W112) against β-amyloid (Aβ)-induced AD pathology and its possible mechanism were explored both in vitro and in vivo. The results showed that W112 exhibits a neuroprotective role against Aβ-induced cytotoxicity in PC12 cells and improves the learning and memory abilities of Aβ-induced AD-like rats. In addition, the assays of the protein expression revealed that W112 reversed tau hyperphosphorylation and reduced the production of proinflammatory cytokines, tumor necrosis factor-α and interleukin-6, both in vitro and in vivo studies. Further study indicated that the regulation of mitogen-activated protein kinase/nuclear factor-κB pathways played a key role in mediating the neuroprotective effects of W112 against AD-like pathology. W112 may become a potential drug for AD intervention. MDPI 2022-08-08 /pmc/articles/PMC9370156/ /pubmed/35956985 http://dx.doi.org/10.3390/molecules27155035 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
An, Fengmao
Xuan, Xinran
Liu, Zheng
Bian, Ming
Shen, Qingkun
Quan, Zheshan
Zhang, Guowei
Wei, Chengxi
Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models
title Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models
title_full Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models
title_fullStr Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models
title_full_unstemmed Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models
title_short Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models
title_sort anti-inflammatory activity of 4-(4-(heptyloxy)phenyl)-2,4-dihydro-3h-1,2,4-triazol-3-one via repression of mapk/nf-κb signaling pathways in β-amyloid-induced alzheimer’s disease models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370156/
https://www.ncbi.nlm.nih.gov/pubmed/35956985
http://dx.doi.org/10.3390/molecules27155035
work_keys_str_mv AT anfengmao antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels
AT xuanxinran antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels
AT liuzheng antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels
AT bianming antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels
AT shenqingkun antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels
AT quanzheshan antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels
AT zhangguowei antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels
AT weichengxi antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels